Robert Mitzman, a director of Esquire Financial Holdings, Inc. ( Nasdaq : ESQ), filed a Form 4 with the U.S. Securities and Exchange Commission on August 3, 2026, disclosing the sale of 3,000 shares of common stock on July 30, 2026.
Key Highlights
- Reporting person: Robert Mitzman, identified as a director of Esquire Financial Holdings, Inc.
- Transaction: 3,000 shares of common stock disposed of (transaction code S) on July 30, 2026, at $129.5973 per share.
- Direct ownership after sale: 139,679 shares of common stock held directly following the reported transaction.
- Indirect holdings: An additional 2,500 shares held indirectly through insurance trust I and 2,500 shares held indirectly through insurance trust II.
- Restricted stock footnotes: The direct holdings include multiple tranches of restricted stock with vesting schedules spanning December 2026 through December 2027.
- No derivative securities: Table II of the filing contains no reported derivative security transactions or holdings.
Mitzman's July 2026 Share Disposal and Ownership Position at Esquire Financial
According to the filing, Robert Mitzman sold 3,000 shares of Esquire Financial Holdings common stock on July 30, 2026, at a price of $129.5973 per share. The transaction is coded "S," indicating an open-market sale. Esquire Financial Holdings, Inc. is a bank Holding Company traded on NASDAQ under the ticker ESQ. The filing was signed by Gary A. Lax pursuant to a Power of Attorney and submitted on August 3, 2026.
Following the sale, the filing reports that Mitzman directly holds 139,679 shares of common stock. The filing's footnotes clarify that these direct holdings include several tranches of restricted stock subject to future vesting: one Tranche vesting 100% on December 10, 2026, and additional tranches vesting in three equal annual installments commencing on December 16, 2024; December 9, 2025; December 19, 2026; December 3, 2027; and December 15, 2027, respectively.
Beyond the direct position, the filing discloses that Mitzman holds an additional 2,500 shares indirectly through an entity identified as insurance trust I and a further 2,500 shares indirectly through insurance trust II. Table II of the filing, which covers derivative securities such as Options , warrants, and convertible instruments, lists no transactions or positions, indicating that no derivative securities were acquired, disposed of, or beneficially owned in connection with this report.
What Was Disclosed
The filing reports a single open-market sale of 3,000 common shares at $129.5973 per share on July 30, 2026, by director Robert Mitzman, leaving him with 139,679 directly held shares and 5,000 shares held indirectly through two insurance trusts. Verified against source; unverifiable items removed.



Please wait processing your request...